| First Author | Steimle JD | Year | 2022 |
| Journal | JCI Insight | Volume | 7 |
| Issue | 11 | PubMed ID | 35471998 |
| Mgi Jnum | J:326224 | Mgi Id | MGI:7294932 |
| Doi | 10.1172/jci.insight.158895 | Citation | Steimle JD, et al. (2022) Decoding the PITX2-controlled genetic network in atrial fibrillation. JCI Insight 7(11):e158895 |
| abstractText | Atrial fibrillation (AF), the most common sustained cardiac arrhythmia and a major risk factor for stroke, often arises through ectopic electrical impulses derived from the pulmonary veins (PVs). Sequence variants in enhancers controlling expression of the transcription factor PITX2, which is expressed in the cardiomyocytes (CMs) of the PV and left atrium (LA), have been implicated in AF predisposition. Single nuclei multiomic profiling of RNA and analysis of chromatin accessibility combined with spectral clustering uncovered distinct PV- and LA-enriched CM cell states. Pitx2-mutant PV and LA CMs exhibited gene expression changes consistent with cardiac dysfunction through cell type-distinct, PITX2-directed, cis-regulatory grammars controlling target gene expression. The perturbed network targets in each CM were enriched in distinct human AF predisposition genes, suggesting combinatorial risk for AF genesis. Our data further reveal that PV and LA Pitx2-mutant CMs signal to endothelial and endocardial cells through BMP10 signaling with pathogenic potential. This work provides a multiomic framework for interrogating the basis of AF predisposition in the PVs of humans. |
